FRASCA ed altri: Nuove disposizioni per la revisione dei prezzi delle specialità medicinali

This procedure concerns new rules for how the prices of specialized medicines are reviewed in Italy. It aims to update the existing framework for price adjustments. The changes will affect pharmaceutical companies and potentially the availability and cost of certain medicines for patients and the healthcare system.